Literature DB >> 30475231

Blocking HIV-1 replication: are Fc-Fcγ receptor interactions required?

Donald Forthal1,2, Andrés Finzi3,4.   

Abstract

Interactions between IgG Fc and its receptors (FcγRs) have been shown to augment broadly neutralizing Ab-mediated (BnAb-mediated) protection from simian-human immunodeficiency virus (SHIV) challenge. In the current issue of the JCI, Parsons and collaborators compared the BnAb PGT121 with a version engineered to have impaired FcγR binding for their ability to protect macaques from an intravenous challenge with SHIV-infected cells as well as to treat already infected animals. Unexpectedly, and in contrast to previous studies, both versions of the Ab were equally able to prevent infection and decrease viral loads in infected animals. Thus, FcγR engagement does not always improve the in vivo antiviral activity of BnAbs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30475231      PMCID: PMC6307933          DOI: 10.1172/JCI125264

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  8 in total

1.  A mouse model for HIV-1 entry.

Authors:  John Pietzsch; Henning Gruell; Stylianos Bournazos; Bridget M Donovan; Florian Klein; Ron Diskin; Michael S Seaman; Pamela J Bjorkman; Jeffrey V Ravetch; Alexander Ploss; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

2.  Fc receptor but not complement binding is important in antibody protection against HIV.

Authors:  Ann J Hessell; Lars Hangartner; Meredith Hunter; Carin E G Havenith; Frank J Beurskens; Joost M Bakker; Caroline M S Lanigan; Gary Landucci; Donald N Forthal; Paul W H I Parren; Preston A Marx; Dennis R Burton
Journal:  Nature       Date:  2007-09-06       Impact factor: 49.962

Review 3.  Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.

Authors:  Dennis R Burton; Lars Hangartner
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

4.  Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques.

Authors:  Matthew S Parsons; Wen Shi Lee; Anne B Kristensen; Thakshila Amarasena; Georges Khoury; Adam K Wheatley; Arnold Reynaldi; Bruce D Wines; P Mark Hogarth; Miles P Davenport; Stephen J Kent
Journal:  J Clin Invest       Date:  2018-11-26       Impact factor: 14.808

5.  Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo.

Authors:  Ching-Lan Lu; Dariusz K Murakowski; Stylianos Bournazos; Till Schoofs; Debolina Sarkar; Ariel Halper-Stromberg; Joshua A Horwitz; Lilian Nogueira; Jovana Golijanin; Anna Gazumyan; Jeffrey V Ravetch; Marina Caskey; Arup K Chakraborty; Michel C Nussenzweig
Journal:  Science       Date:  2016-05-05       Impact factor: 47.728

6.  Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.

Authors:  Stylianos Bournazos; Florian Klein; John Pietzsch; Michael S Seaman; Michel C Nussenzweig; Jeffrey V Ravetch
Journal:  Cell       Date:  2014-09-11       Impact factor: 41.582

7.  Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.

Authors:  Joshua A Horwitz; Yotam Bar-On; Ching-Lan Lu; Daniela Fera; Ainsley A K Lockhart; Julio C C Lorenzi; Lilian Nogueira; Jovana Golijanin; Johannes F Scheid; Michael S Seaman; Anna Gazumyan; Susan Zolla-Pazner; Michel C Nussenzweig
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

8.  Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Authors:  Dan H Barouch; James B Whitney; Brian Moldt; Florian Klein; Thiago Y Oliveira; Jinyan Liu; Kathryn E Stephenson; Hui-Wen Chang; Karthik Shekhar; Sanjana Gupta; Joseph P Nkolola; Michael S Seaman; Kaitlin M Smith; Erica N Borducchi; Crystal Cabral; Jeffrey Y Smith; Stephen Blackmore; Srisowmya Sanisetty; James R Perry; Matthew Beck; Mark G Lewis; William Rinaldi; Arup K Chakraborty; Pascal Poignard; Michel C Nussenzweig; Dennis R Burton
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

  8 in total
  4 in total

1.  A MUC16 IgG Binding Activity Selects for a Restricted Subset of IgG Enriched for Certain Simian Immunodeficiency Virus Epitope Specificities.

Authors:  Jeffrey R Schneider; Xiaoying Shen; Chiara Orlandi; Tinashe Nyanhete; Sheetal Sawant; Ann M Carias; Archer D Smith; Neil L Kelleher; Ronald S Veazey; George K Lewis; Georgia D Tomaras; Thomas J Hope
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

Review 2.  Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses.

Authors:  Matthew Zirui Tay; Kevin Wiehe; Justin Pollara
Journal:  Front Immunol       Date:  2019-02-28       Impact factor: 7.561

Review 3.  Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.

Authors:  Bin Su; Stefania Dispinseri; Valeria Iannone; Tong Zhang; Hao Wu; Raphael Carapito; Seiamak Bahram; Gabriella Scarlatti; Christiane Moog
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

4.  Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells.

Authors:  Sai Priya Anand; Shilei Ding; William D Tolbert; Jérémie Prévost; Jonathan Richard; Hwi Min Gil; Gabrielle Gendron-Lepage; Wing-Fai Cheung; Haifeng Wang; Rebecca Pastora; Hirak Saxena; Warren Wakarchuk; Halima Medjahed; Bruce D Wines; Mark Hogarth; George M Shaw; Malcom A Martin; Dennis R Burton; Lars Hangartner; David T Evans; Marzena Pazgier; Doug Cossar; Michael D McLean; Andrés Finzi
Journal:  J Virol       Date:  2021-08-25       Impact factor: 6.549

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.